Ardent Health (NYSE:ARDT) Price Target Raised to $21.00

Ardent Health (NYSE:ARDT) had its target price lifted by research analysts at Stephens from $13.00 to $21.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Stephens‘s price target indicates a potential upside of 21.92% from the stock’s previous close.

A number of other equities analysts also recently commented on ARDT. Royal Bank Of Canada upped their target price on Ardent Health from $13.00 to $18.00 and gave the company an “outperform” rating in a report on Friday. Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. BMO Capital Markets began coverage on shares of Ardent Health in a research report on Tuesday, September 22nd. They issued a “market perform” rating and a $11.00 target price for the company. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Monday, September 7th. Finally, Leerink Partners reaffirmed an “outperform” rating and set a $14.00 target price on shares of Ardent Health in a research note on Friday, September 18th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $13.54.

Ardent Health Trading Up 8.3%

Shares of ARDT stock traded up $1.32 during mid-day trading on Friday, reaching $17.23. The stock had a trading volume of 2,747,768 shares, compared to its average volume of 474,621. The firm has a market capitalization of $2.43 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 3.68 and a beta of 0.58. The stock’s 50-day moving average price is $11.32 and its two-hundred day moving average price is $10.05. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. Ardent Health has a 52-week low of $7.71 and a 52-week high of $17.67.

Ardent Health (NYSE:ARDT) last posted its earnings results on Wednesday, November 4th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.08. Ardent Health had a return on equity of 8.49% and a net margin of 2.27%. The company had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.60 billion. Equities analysts expect that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

A number of institutional investors have recently added to or reduced their stakes in ARDT. Russell Investments Group Ltd. boosted its holdings in shares of Ardent Health by 3.2% during the 3rd quarter. Russell Investments Group Ltd. now owns 69,827 shares of the company’s stock valued at $724,000 after buying an additional 2,145 shares in the last quarter. R Squared Ltd increased its stake in shares of Ardent Health by 35.1% in the 3rd quarter. R Squared Ltd now owns 16,468 shares of the company’s stock worth $170,000 after acquiring an additional 4,275 shares in the last quarter. Fifth Third Bancorp increased its stake in shares of Ardent Health by 5.5% in the 3rd quarter. Fifth Third Bancorp now owns 92,186 shares of the company’s stock worth $953,000 after acquiring an additional 4,773 shares in the last quarter. Brighton Jones LLC purchased a new position in Ardent Health during the 3rd quarter valued at about $110,000. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in Ardent Health during the 3rd quarter valued at about $61,000.

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.